FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

21531711000001100: Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2884551000001119 Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2884561000001116 Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Is a Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has active ingredient Caffeine false Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has specific active ingredient Caffeine true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Is a Panadol Period Pain true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) 14 tablet 2 x 7 tablets Has AMP True Panadol Period Pain 500mg/65mg tablets (Haleon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start